Are peptides legal in Portugal?
Sourced guide to the legal status of peptides in Portugal, refreshed automatically from live research.
Overall Status: Restricted
Short answer: Peptides are restricted in Portugal: pharmaceutical peptides with marketing authorization, such as semaglutide (Ozempic/Wegovy) and somatropin (HGH), are legal only as prescription-only medicines under INFARMED's oversight, while unapproved research peptides like BPC-157 and TB-500 cannot be lawfully sold or marketed for human use and instead circulate in an unregulated 'research chemical' gray market.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides in Portugal are restricted rather than freely legal: the national medicines statute requires that any product presented for a therapeutic purpose obtain a marketing authorization before it can be sold or prescribed, and INFARMED (the national medicines authority) enforces this framework against unauthorized products. Approved peptide drugs such as GLP-1 agonists and growth-hormone products are treated as prescription-only medicines. Non-approved peptides such as BPC-157 and TB-500 are not recognized as medicines in Portugal; they are typically sold and imported as 'research use only' laboratory reagents, which places them outside the Estatuto do Medicamento as long as no human-use or therapeutic claims are made, but selling or using them as drugs for human consumption is not lawful under that statute.
Key Points
- Portugal's Decreto-Lei n.º 176/2006 (Estatuto do Medicamento) establishes the national legal regime for human medicines and is the law INFARMED applies to any product presented for a therapeutic purpose, including peptides marketed as treatments. [1]
- BPC-157 is not an authorized medicine in Portugal, and INFARMED applies Decreto-Lei n.º 176/2006 to any peptide product that is presented or marketed with a therapeutic purpose. [3]
- A peptide sold strictly as a labeled 'research use only' laboratory reagent, without any human-use or therapeutic claim, falls outside the scope of Portugal's Estatuto do Medicamento and is treated as a research reagent rather than a medicine. [3]
- Personal import of research peptides into Portugal from another EU member state generally avoids customs clearance, import VAT, and duties, while orders from non-EU countries (e.g. Switzerland, the UK, the US, China) are subject to Portugal's customs and import-VAT regime, including 23% VAT and the low-value consignment exemption changes that took effect in July 2026. [3]
- Bringing or buying unapproved research peptides such as BPC-157 or TB-500 into Portugal for personal human use is not a lawful medicine purchase under the Estatuto do Medicamento, even though such items are frequently sold online as laboratory reagents rather than drugs. [3]
- Approved peptide-based drugs (such as GLP-1 receptor agonists and growth-hormone/somatropin products) are dispensed in Portugal only through a valid medical prescription, consistent with the prescription-medicine rules set out under the national Estatuto do Medicamento framework. [1]
- No Portugal-specific enforcement action, ministerial warning, or 2023-2026 legislative amendment naming BPC-157, TB-500, or 'research peptides' specifically was found in available sources; enforcement in this area appears to proceed under the general medicines and customs framework rather than a peptide-specific rule. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Portugal
| BPC-157 | BPC-157 is not an authorized medicine in Portugal and cannot lawfully be sold or marketed for human therapeutic use, though it is commonly sold online as an unregulated 'research use only' laboratory reagent. [3] |
|---|
| Semaglutide / GLP-1 class (e.g. Ozempic, Wegovy) | Semaglutide-class GLP-1 medicines are regulated in Portugal as prescription-only pharmaceutical products under the national Estatuto do Medicamento, meaning they can only be legally obtained with a valid medical prescription rather than purchased as unregulated peptides. [1] |
|---|
| TB-500 | TB-500 has no marketing authorization as a medicine in Portugal, so it falls under the same unauthorized-for-human-use status as other unapproved research peptides and is typically sold only as a labeled research chemical rather than a legal drug. |
|---|
| Human Growth Hormone (HGH / somatropin) | Somatropin (recombinant HGH) is an approved prescription medicine in Portugal that is dispensed only through a doctor's prescription under the national medicines statute, not sold as an unregulated peptide. [1] |
|---|
Last researched: 2026-09-10
Frequently asked questions
You cannot lawfully buy an approved peptide medicine (such as a GLP-1 drug or HGH/somatropin) in Portugal without a prescription, since these are prescription-only medicines under the national Estatuto do Medicamento; unapproved peptides like BPC-157 are instead sold outside pharmacies as 'research use only' products rather than as legal over-the-counter drugs.
[1]
Importing unapproved research peptides like BPC-157 into Portugal is not the same as a lawful medicine purchase, but such orders are commonly shipped as labeled research chemicals; goods from within the EU generally clear without customs/import VAT, while non-EU orders are subject to Portuguese customs duties and 23% import VAT under rules updated in July 2026.
[3]
No source was found confirming Portugal-specific telehealth prescribing rules for peptide medicines such as semaglutide, so this remains unsourced; in general, any prescription-only medicine in Portugal requires a valid medical prescription issued under the national medicines framework regardless of the consultation format.
No specific Portuguese enforcement case or penalty schedule targeting BPC-157 or TB-500 sales was found in available sources, so this point is unsourced; in general, marketing an unauthorized product for a therapeutic purpose falls under INFARMED's enforcement of the Decreto-Lei n.º 176/2006 medicines statute.
[1]
HGH (somatropin) is legal in Portugal only as a prescription pharmaceutical product regulated under the national Estatuto do Medicamento, meaning it cannot be lawfully bought over the counter or online outside a licensed pharmacy with a doctor's prescription.
[1]